DCX and Alzheimer disease: DCX immunostaining further revealed increased neurogenesis in the SGZ following Yohimbine treatment, evidenced by a significant rise in newborn neuron numbers compared to the AD + Dex (50 μg/kg) group (p < 0.01, Figures 5G,H), suggesting a reactivation of aberrant neurogenesis.